Groh Nicole, Bühler Anika, Huang Chaolie, Li Ka Wan, van Nierop Pim, Smit August B, Fändrich Marcus, Baumann Frank, David Della C
Protein Aggregation and Aging, German Center for Neurodegenerative DiseasesTübingen, Germany.
Graduate School of Cellular and Molecular NeuroscienceTübingen, Germany.
Front Aging Neurosci. 2017 May 17;9:138. doi: 10.3389/fnagi.2017.00138. eCollection 2017.
Aging is the most important risk factor for neurodegenerative diseases associated with pathological protein aggregation such as Alzheimer's disease. Although aging is an important player, it remains unknown which molecular changes are relevant for disease initiation. Recently, it has become apparent that widespread protein aggregation is a common feature of aging. Indeed, several studies demonstrate that 100s of proteins become highly insoluble with age, in the absence of obvious disease processes. Yet it remains unclear how these misfolded proteins aggregating with age affect neurodegenerative diseases. Importantly, several of these aggregation-prone proteins are found as minor components in disease-associated hallmark aggregates such as amyloid-β plaques or neurofibrillary tangles. This co-localization raises the possibility that age-dependent protein aggregation directly contributes to pathological aggregation. Here, we show for the first time that highly insoluble proteins from aged or aged mouse brains, but not from young individuals, can initiate amyloid-β aggregation . We tested the seeding potential at four different ages across the adult lifespan of . Significantly, protein aggregates formed during the early stages of aging did not act as seeds for amyloid-β aggregation. Instead, we found that changes in protein aggregation occurring during middle-age initiated amyloid-β aggregation. Mass spectrometry analysis revealed several late-aggregating proteins that were previously identified as minor components of amyloid-β plaques and neurofibrillary tangles such as 14-3-3, Ubiquitin-like modifier-activating enzyme 1 and Lamin A/C, highlighting these as strong candidates for cross-seeding. Overall, we demonstrate that widespread protein misfolding and aggregation with age could be critical for the initiation of pathogenesis, and thus should be targeted by therapeutic strategies to alleviate neurodegenerative diseases.
衰老是与病理性蛋白质聚集相关的神经退行性疾病(如阿尔茨海默病)最重要的风险因素。尽管衰老起着重要作用,但与疾病起始相关的分子变化仍不清楚。最近,很明显广泛的蛋白质聚集是衰老的一个共同特征。事实上,几项研究表明,在没有明显疾病过程的情况下,数百种蛋白质会随着年龄增长而变得高度不溶。然而,这些随年龄增长而聚集的错误折叠蛋白质如何影响神经退行性疾病仍不清楚。重要的是,这些易于聚集的蛋白质中有几种是在与疾病相关的标志性聚集体(如淀粉样β斑块或神经原纤维缠结)中作为次要成分被发现的。这种共定位增加了年龄依赖性蛋白质聚集直接导致病理性聚集的可能性。在这里,我们首次表明,来自老年或老年小鼠大脑而非年轻个体的高度不溶蛋白质可以引发淀粉样β聚集。我们在整个成年寿命的四个不同年龄测试了播种潜力。值得注意的是,在衰老早期形成的蛋白质聚集体并没有作为淀粉样β聚集的种子。相反,我们发现中年期间发生的蛋白质聚集变化引发了淀粉样β聚集。质谱分析揭示了几种先前被确定为淀粉样β斑块和神经原纤维缠结次要成分的晚期聚集蛋白质,如14-3-3、泛素样修饰激活酶1和核纤层蛋白A/C,突出了它们作为交叉播种的有力候选者。总体而言,我们证明随着年龄增长广泛的蛋白质错误折叠和聚集可能对发病机制的起始至关重要,因此应该成为缓解神经退行性疾病的治疗策略的目标。